Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transcription factors can be sequestered at specific organelles and translocate to the nucleus in response to changes in organellar homeostasis.
MondoA
is a basic helix-loop-helix leucine zipper
transcriptional activator
similar to Myc in function. However, unlike Myc,
MondoA
and its binding partner Mlx localize to the cytoplasm, suggesting tight regulation of their nuclear function. We show here that endogenous
MondoA
and Mlx associate with mitochondria in primary skeletal muscle cells and erythroblast K562 cells. Interaction between
MondoA
and the mitochondria is salt and protease sensitive, demonstrating that it associates with the outer mitochondrial membrane by binding a protein partner. Further, endogenous
MondoA
shuttles between the mitochondria and the nucleus, suggesting that it communicates between these two organelles. When nuclear,
MondoA
activates transcription of a broad spectrum of metabolic genes, including those for the glycolytic enzymes lactate dehydrogenase A, hexokinase II, and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3. Regulation of these three targets is mediated by direct interaction with CACGTG sites in their promoters. Consistent with its regulation of glycolytic targets,
MondoA
is both necessary and sufficient for glycolysis. We propose that
MondoA
communicates information about the intracellular energy state between the mitochondria and the nucleus, resulting in transcriptional activation of glycolytic target genes.
...
PMID:MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis. 1678 75